findmyKOL
Clinical trialNCT03587844RecruitingPhase 2Interventional

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

SponsorMemorial Sloan Kettering Cancer CenterEnrollment58Lymphomatoid PapulosisMycosis FungoidesSezary Syndrome
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University Medical Center

    Stanford, California, United States

    Recruiting
  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey, United States

    Recruiting
  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, United States

    Recruiting
  • Memorial Sloan Kettering Bergen

    Montvale, New Jersey, United States

    Recruiting
  • Memorial Sloan Kettering Commack

    Commack, New York, United States

    Recruiting
  • Memorial Sloan Kettering Westchester

    East White Plains, New York, United States

    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Alison Moskowitz, MD
    Recruiting
  • Memorial Sloan Kettering Nassau

    Uniondale, New York, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Jul 2018
Primary completion
31 Jul 2027
Completion
31 Jul 2027
Last update posted
3 Apr 2026
Registered enrollment
58
Registry id
NCT03587844

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.